1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceutical Analysis & Statistics in Japan, January 2017 (p3)

Pharmaceutical Analysis & Statistics in Japan, January 2017 (p3)

61-90 of about 800 reports

Purchase Reports From Reputable Market Research Publishers

Methicillin - Epidemiology Forecast To 2023

Methicillin - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Methicillin - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Methicillin in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It ...

  • Industries : Therapy
  • Countries : United Kingdom, Germany, France, Italy, Spain, Japan
Erectile Dysfunction  - Epidemiology Forecast To 2023

Erectile Dysfunction  - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Erectile Dysfunction  - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Erectile Dysfunction  in seven major markets (US, France, Germany, Italy, Spain, ...

  • Industries : Therapy
  • Countries : United Kingdom, Germany, France, Italy, Spain, Japan
Irritable Bowel Syndrome - Epidemiology Forecast To 2023

Irritable Bowel Syndrome - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Irritable Bowel Syndrome - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Irritable Bowel Syndrome in seven major markets (US, France, Germany, Italy, ...

  • Industries : Pathology, OTC
  • Countries : United Kingdom, Germany, France, Italy, Spain, Japan
Dermatophytic Onychomycosis - Epidemiology Forecast To 2023

Dermatophytic Onychomycosis - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Dermatophytic Onychomycosis - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Dermatophytic Onychomycosis in seven major markets (US, France, Germany, ...

  • Industries : Pathology, OTC
  • Countries : United Kingdom, Germany, France, Italy, Spain, Japan
Urinary Incontinence  - Epidemiology Forecast To 2023

Urinary Incontinence  - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Urinary Incontinence  - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Urinary Incontinence  in seven major markets (US, France, Germany, Italy, Spain, ...

  • Industries : OTC
  • Countries : United Kingdom, Germany, France, Italy, Spain, Japan
Dysmenorrhea  - Epidemiology Forecast To 2023

Dysmenorrhea  - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Dysmenorrhea  - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Dysmenorrhea  in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). ...

  • Industries : OTC
  • Countries : United Kingdom, Germany, France, Italy, Spain, Japan
Chemotherapy Induced Neutropenia  - Epidemiology Forecast To 2023

Chemotherapy Induced Neutropenia  - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Chemotherapy Induced Neutropenia  - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Chemotherapy Induced Neutropenia  in seven major markets (US, France, ...

  • Industries : Therapy
  • Countries : United Kingdom, Germany, France, Italy, Spain, Japan
Allergic Rhinitis - Epidemiology Forecast To 2023

Allergic Rhinitis - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Allergic Rhinitis - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Allergic Rhinitis in seven major markets (US, France, Germany, Italy, Spain, UK and ...

  • Industries : OTC, Chronic Disease, Pathology
  • Countries : United Kingdom, Germany, France, Italy, Spain, Japan
Androgenic Alopecia - Pipeline Review, H2 2016

Androgenic Alopecia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

Androgenic Alopecia - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Androgenic Alopecia – Pipeline Review, H2 2016, provides an ...

  • Industries : OTC, Pharmaceutical
  • Countries : Japan
2017-2021 Emerging Opportunities in the Japanese Endocrine Function Testing Market: Hospitals and Commercial Labs--Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review

2017-2021 Emerging Opportunities in the Japanese Endocrine Function Testing Market: Hospitals and Commercial Labs--Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review

  • $ 1700
  • Industry report
  • February 2017
  • by Venture Planning Group

This new 269-page report from VPGMarketResearch.com provides a comprehensive analysis in the Japanese endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts ...

  • Industries : Therapy
  • Countries : Japan
2017-2021 Japan Endocrine Function Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

2017-2021 Japan Endocrine Function Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 1700
  • Industry report
  • February 2017
  • by Venture Planning Group

This new 269-page report from VPGMarketResearch.com provides a comprehensive analysis in the Japanese endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts ...

  • Industries : Therapy
  • Countries : Japan
2016-2021  Japan Endocrine Function Testing Market: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts

2016-2021 Japan Endocrine Function Testing Market: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts

  • $ 1700
  • Industry report
  • November 2016
  • by Venture Planning Group

This new 269-page report from VPGMarketResearch.com provides a comprehensive analysis in the Japanese endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts ...

  • Industries : Therapy
  • Countries : Japan
2016-2021  Japan Therapeutic Drug Monitoring (TDM) Market: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts

2016-2021 Japan Therapeutic Drug Monitoring (TDM) Market: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts

  • $ 1700
  • Industry report
  • November 2016
  • by Venture Planning Group

This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales ...

  • Industries : Therapy
  • Countries : Japan
2016-2021  Japan Drugs of Abuse Testing Market: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts

2016-2021 Japan Drugs of Abuse Testing Market: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts

  • $ 1700
  • Industry report
  • November 2016
  • by Venture Planning Group

This new 260-page report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, ...

  • Industries : Therapy
  • Countries : Japan
Shionogi & Co Ltd - Product Pipeline Review - 2016

Shionogi & Co Ltd - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • December 2016
  • by Global Markets Direct

Shionogi & Co Ltd - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Shionogi & Co Ltd - Product Pipeline Review - 2016’, provides an overview of the Shionogi & Co Ltd’s pharmaceutical ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : World, Japan
Kissei Pharmaceutical Co Ltd - Product Pipeline Review - 2016

Kissei Pharmaceutical Co Ltd - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • December 2016
  • by Global Markets Direct

Kissei Pharmaceutical Co Ltd - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Kissei Pharmaceutical Co Ltd - Product Pipeline Review - 2016’, provides an overview of the Kissei ...

  • Industries : Pharmaceutical
  • Countries : World, Japan
Sumitomo Dainippon Pharma Co Ltd - Product Pipeline Review - 2016

Sumitomo Dainippon Pharma Co Ltd - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • December 2016
  • by Global Markets Direct

Sumitomo Dainippon Pharma Co Ltd - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Sumitomo Dainippon Pharma Co Ltd - Product Pipeline Review - 2016’, provides an overview of the ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States, World, Japan
Kyorin Pharmaceutical Co Ltd - Product Pipeline Review - 2016

Kyorin Pharmaceutical Co Ltd - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • December 2016
  • by Global Markets Direct

Kyorin Pharmaceutical Co Ltd - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Kyorin Pharmaceutical Co Ltd - Product Pipeline Review - 2016’, provides an overview of the Kyorin ...

  • Industries : Pharmaceutical, Pathology, Therapy
  • Countries : World, Japan
Key Pharma News 05 DECEMBER 2016

Key Pharma News 05 DECEMBER 2016

  • $ 1706
  • Industry report
  • December 2016
  • by Espicom Business Intelligence

Industry Trend Analysis - Allergan Acquisitions Will Continue Industry Trend Analysis - Burgeoning Medical Cannabis Industry Will See Increasing Major Pharma Interest Industry Brief - Novartis Acquires ...

  • Industries : Pharmaceutical
  • Countries : Japan
Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

  • $ 1200
  • Industry report
  • February 2017
  • by International Market Analysis Research and Consult

IMARC’s new report “Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Japanese diabetes market. ...

  • Industries : Chronic Disease, Therapy, Pathology
  • Countries : Japan
Cancer Drug News 19 DECEMBER 2016

Cancer Drug News 19 DECEMBER 2016

  • $ 1334
  • Industry report
  • December 2016
  • by Espicom Business Intelligence

Industry Trend Analysis - ASH Data Support CAR-T Therapies' 2017 Market Entry Industry Trend Analysis - Long-Term Data Will Aid In Protecting Older Cancer Drug Revenue Streams Industry Brief - First Patient ...

  • Industries : Therapy
  • Countries : Europe, Canada, Japan
Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations

Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations

  • $ 1000
  • Industry report
  • November 2016
  • by Cancer Research Analytics

“Oncology drugs report - Neupogen and Neulasta - filgrastim franchise - 1991-2015 analysis; 2016-2021 expectations” is a comprehensive report on Neupogen and Neulasta, two market leading drugs (by ...

  • Industries : Biotechnology, Biological Therapy, Biopharmaceutical, Generic Drug, Pharmaceutical, Therapy
  • Countries : Japan, Asia
Generics in Japan, MarketLine

Generics in Japan, MarketLine

  • $ 350
  • Industry report
  • January 2017
  • by MarketLine

Summary Generics in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains ...

  • Industries : Pharmaceutical
  • Countries : Japan
Sawai Pharmaceutical Co Ltd (4555) - Financial and Strategic SWOT Analysis Review

Sawai Pharmaceutical Co Ltd (4555) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2017
  • by GlobalData

Summary Sawai Pharmaceutical Co Ltd (Sawai Pharmaceutical) is a pharmaceutical company that manufactures, sells, imports and exports pharmaceutical products. The company’s products include cardiovascula ...

  • Industries : Pharmaceutical
  • Countries : Japan
Torii Pharmaceutical Co Ltd (4551) - Financial and Strategic SWOT Analysis Review

Torii Pharmaceutical Co Ltd (4551) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2017
  • by GlobalData

Summary Torii Pharmaceutical Co Ltd (Torii) a subsidiary of Japan Tobacco Inc is a pharmaceutical company that manufactures and markets products such as antebate ointment, antebate cream and urinorm used ...

  • Industries : Pharmaceutical
  • Countries : Japan
Wakamoto Pharmaceutical Co Ltd (4512) - Financial and Strategic SWOT Analysis Review

Wakamoto Pharmaceutical Co Ltd (4512) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2017
  • by GlobalData

Summary Wakamoto Pharmaceutical Co Ltd (Wakamoto) is a pharmaceutical company that manufactures and markets prescription drugs and pharmaceuticals. The company manufactures and sells ethical drugs and ...

  • Industries : Pharmaceutical
  • Countries : Japan
Oncology drug report - Vidaza - azacitidine - 2004-2015 analysis; 2016-2021 expectations

Oncology drug report - Vidaza - azacitidine - 2004-2015 analysis; 2016-2021 expectations

  • $ 300
  • Industry report
  • December 2016
  • by Cancer Research Analytics

Vidaza: Top drug losing sheen” is a comprehensive drug report on the largest drug in the MDS space that seems to be falling apart post its patent expiry. Vidaza is the fourth-largest drug in Celgene’s ...

  • Industries : Cancer, Pathology
  • Countries : Japan
Oncology drug report - Perjeta - pertuzumab - 2012-2015 analysis; 2016-2021 expectations

Oncology drug report - Perjeta - pertuzumab - 2012-2015 analysis; 2016-2021 expectations

  • $ 300
  • Industry report
  • December 2016
  • by Cancer Research Analytics

“Perjeta (pertuzumab): In the spotlight” is a comprehensive report on the first and only USFDA approved drug for eoadjuvant breast cancer treatment. Perjeta falls in the monoclonal antibody, HER2 dimerization ...

  • Industries : Therapy, Oncology
  • Countries : Europe, Japan, World, Asia
Oncology drug report - Herceptin - trastuzumab - 2006-2015 analysis; 2016-2021 expectations

Oncology drug report - Herceptin - trastuzumab - 2006-2015 analysis; 2016-2021 expectations

  • $ 300
  • Industry report
  • November 2016
  • by Cancer Research Analytics

“Herceptin (trastuzumab): 2006-2015 analysis; 2016-2021 expectations” is a comprehensive report on the second-largest oncology drug by 2015 sales. Herceptin falls in the monoclonal antibody, HER2 inhibitor, ...

  • Industries : Therapy, Oncology
  • Countries : Europe, Japan, World
NanoCarrier Co Ltd (4571) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NanoCarrier Co Ltd (4571) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary NanoCarrier Co Ltd (NanoCarrier) is a biotechnology company that researches, develops and produces pharmaceuticals using micellar nanoparticles technology. The company’s research and development ...

  • Industries : Biotechnology, Drug Delivery
  • Countries : Japan
About 1500 reports

Download Unlimited Documents from Trusted Public Sources

OTC Market Segment in Japan

  • February 2017
  • OTC  

    Cement  

  • Japan  

View report >

Otc Industry In Japan

February 2017

Hormone Market In Japan

February 2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.